Key result
Biomarker profiling and risk stratification in cardiovascular disease during pregnancy was not evaluated because the publisher withdrew this article due to accidental duplication.
Key points are not available for this paper at this time.
Withdrawal due to duplication prevents evaluation of biomarker profiling for risk stratification in pregnant CVD patients; leaves open need for future studies.
The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/<10.1016/j.ijcchd.2021.100206>. The duplicate article has therefore been withdrawn. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal
No takes yet. Share an insight, caveat, or question.
Farhan et al. (2022) studied this question. Biomarker profiling and risk stratification in cardiovascular disease during pregnancy was not evaluated because the publisher withdrew this article due to accidental duplication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: